577 related articles for article (PubMed ID: 24090701)
21. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
Aptula AO; Patlewicz G; Roberts DW; Schultz TW
Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
[TBL] [Abstract][Full Text] [Related]
22. Integrated decision strategies for skin sensitization hazard.
Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
[TBL] [Abstract][Full Text] [Related]
23. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network-based risk assessment model of skin sensitization.
Hirota M; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Takenouchi O; Ashikaga T; Miyazawa M
J Appl Toxicol; 2015 Nov; 35(11):1333-47. PubMed ID: 25824844
[TBL] [Abstract][Full Text] [Related]
25. A mechanistic approach to modeling respiratory sensitization.
Mekenyan O; Patlewicz G; Kuseva C; Popova I; Mehmed A; Kotov S; Zhechev T; Pavlov T; Temelkov S; Roberts DW
Chem Res Toxicol; 2014 Feb; 27(2):219-39. PubMed ID: 24422459
[TBL] [Abstract][Full Text] [Related]
26. Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization.
Patlewicz G; Kuseva C; Kesova A; Popova I; Zhechev T; Pavlov T; Roberts DW; Mekenyan O
Regul Toxicol Pharmacol; 2014 Aug; 69(3):529-45. PubMed ID: 24928565
[TBL] [Abstract][Full Text] [Related]
27. Probabilistic hazard assessment for skin sensitization potency by dose-response modeling using feature elimination instead of quantitative structure-activity relationships.
Luechtefeld T; Maertens A; McKim JM; Hartung T; Kleensang A; Sá-Rocha V
J Appl Toxicol; 2015 Nov; 35(11):1361-1371. PubMed ID: 26046447
[TBL] [Abstract][Full Text] [Related]
28. A review of substances found positive in 1 of 3 in vitro tests for skin sensitization.
Kolle SN; Natsch A; Gerberick GF; Landsiedel R
Regul Toxicol Pharmacol; 2019 Aug; 106():352-368. PubMed ID: 31112722
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
30. TIMES-SS--recent refinements resulting from an industrial skin sensitisation consortium.
Patlewicz G; Kuseva C; Mehmed A; Popova Y; Dimitrova G; Ellis G; Hunziker R; Kern P; Low L; Ringeissen S; Roberts DW; Mekenyan O
SAR QSAR Environ Res; 2014; 25(5):367-91. PubMed ID: 24785905
[TBL] [Abstract][Full Text] [Related]
31. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
32. Assessment of a defined approach based on a stacking prediction model to identify skin sensitization hazard.
Tourneix F; Alépée N; Detroyer A; Eilstein J; Martinozzi Teissier S; Nardelli L; Noçairi H; Pauloin T; Piroird C; Del Bufalo A
Toxicol In Vitro; 2019 Oct; 60():134-143. PubMed ID: 31100378
[TBL] [Abstract][Full Text] [Related]
33. In vitro approaches to the identification and characterization of skin sensitizers.
Basketter D; Maxwell G
Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
[TBL] [Abstract][Full Text] [Related]
34. Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals.
Nukada Y; Miyazawa M; Kazutoshi S; Sakaguchi H; Nishiyama N
Toxicol In Vitro; 2013 Mar; 27(2):609-18. PubMed ID: 23149339
[TBL] [Abstract][Full Text] [Related]
35. Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice.
Jaworska J; Dancik Y; Kern P; Gerberick F; Natsch A
J Appl Toxicol; 2013 Nov; 33(11):1353-64. PubMed ID: 23670904
[TBL] [Abstract][Full Text] [Related]
36. SkinSensPred as a Promising in Silico Tool for Integrated Testing Strategy on Skin Sensitization.
Wang SS; Wang CC; Tung CW
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232156
[TBL] [Abstract][Full Text] [Related]
37. Prediction of skin sensitization potency using machine learning approaches.
Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
[TBL] [Abstract][Full Text] [Related]
38. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
[TBL] [Abstract][Full Text] [Related]
39. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
Basketter D; Darlenski R; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
[TBL] [Abstract][Full Text] [Related]
40. Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals.
Bauch C; Kolle SN; Fabian E; Pachel C; Ramirez T; Wiench B; Wruck CJ; van Ravenzwaay B; Landsiedel R
Toxicol In Vitro; 2011 Sep; 25(6):1162-8. PubMed ID: 21669280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
